Lesion progression and plaque composition are not altered in older apoE-/- mice lacking tumor necrosis factor-α receptor p55

Atherosclerosis

Volumn 176, Issue 2, 2004, Pages 227-232

  Blessing, Erwin ^a   Bea, Florian ^a   Kuo, Cho Chou ^a   Campbell, Lee Ann ^a   Chesebro, Brian ^a   Rosenfeld, Michael E ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Atherosclerosis; Hyperlipidemia; Inflammation; Plaque rupture; Tumor necrosis factor

Indexed keywords

APOLIPOPROTEIN E; CYTOKINE; PROTEIN P55; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR ALPHA RECEPTOR;

AGE DISTRIBUTION; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTERY LESION; ARTICLE; ATHEROSCLEROTIC PLAQUE; BODY WEIGHT; BRACHIOCEPHALIC TRUNK; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DISEASE COURSE; HYPERLIPIDEMIA; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; TRIACYLGLYCEROL BLOOD LEVEL; WILD TYPE;

AGING; ANIMALS; APOLIPOPROTEINS E; ARTERIOSCLEROSIS; DISEASE PROGRESSION; HYPERLIPIDEMIAS; MICE; RECEPTORS, TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR-ALPHA;

EID: 5644272886     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2004.05.033     Document Type: Article

References (34)

1. C.A. Smith, T. Farrah, and R.G. Goodwin The TNF receptor superfamily of cellular and viral proteins: activation, costimulation, and death Cell 76 1994 959 962
2. L.A. Tartaglia, M. Rothe, and Y.F. Hu Tumor necrosis factor's cytotoxic activity is signaled by the p55 TNF receptor Cell 73 1993 213 216
3. A.H. Stolpen, E.C. Guinan, and W. Fiers Recombinant tumor necrosis factor and immune interferon act singly and in combination to reorganize human vascular endothelial cell monolayers Am. J. Pathol. 123 1986 16 24
4. J. Pober, and R.S. Cotran What can be learned from the expression of endothelial adhesion molecules in tissues? Lab. Invest. 64 1991 301 305
5. R.S. Cotran, and J.S. Pober Cytokine-endothelial interactions in inflammation, immunity, and vascular injury J. Am. Soc. Nephrol. 1 1990 225 235
6. M. Yoshizumi, S. Kourembanas, and D.H. Temizer Tumor necrosis factor increases transcription of the heparin-binding epidermal growth factor-like growth factor gene in vascular endothelial cells J. Biol. Chem. 267 1992 9467 9469
7. H. Koeffler, J. Gasson, and A. Tobler Transcriptional and posttranscriptional modulation of myeloid colony-stimulating factor expression by tumor necrosis factor and other agents Mol. Cell Biol. 8 1988 3432 3437
8. P. Marucha, R. Zeff, and D. Kreutzer Cytokine-induced IL-1 beta gene expression in the human polymorphonuclear leukocyte: transcriptional and post-transcriptional regulation by tumor necrosis factor and IL-1 J. Immunol. 147 1991 2603 2608
9. L.A. Tartaglia, D.V. Goeddel, and C. Reynolds Stimulation of human T-cell proliferation by specific activation of the 75-kDa tumor necrosis factor receptor J. Immunol. 151 1993 4637 4641
10. M. Grell, E. Douni, and H. Wajant The transmembrane form of tumor necrosis factor is the prime activating ligand of the 80 kDa tumor necrosis factor receptor Cell 83 1995 793 802
11. S.L. Erickson, F.J. de Sauvage, and K. Kikly Decreased sensitivity to tumour-necrosis factor but normal T-cell development in TNF receptor-2-deficient mice Nature 372 1994 560 563
12. J.J. Peschon, D.S. Torrance, and K.L. Stocking TNF receptor-deficient mice reveal divergent roles for p55 and p75 in several models of inflammation J. Immunol. 160 1998 943 952
13. B. Neumann, T. Machleidt, and A. Lifka Crucial role of 55-kilodalton TNF receptor in TNF-induced adhesion molecule expression and leukocyte organ infiltration J. Immunol. 156 1996 1587 1593
14. F. Mackay, H. Loetscher, and D. Stueber Tumor necrosis factor alpha (TNF-alpha)-induced cell adhesion to human endothelial cells is under dominant control of one TNF receptor type TNF-R55 J. Exp. Med. 177 1993 1277 1286
15. Z. Liu, H. Hsu, and D.V. Goeddel Dissection of TNF receptor 1 effector functions: JNK activation is not linked to apoptosis while NF-kappaB activation prevents cell death Cell 87 1996 565 576
16. K. Pfeffer, T. Matsuyama, and T.M. Kundig Mice deficient for the 55 kd tumor necrosis factor receptor are resistant to endotoxic shock, yet succumb to L. monocytogenes infection Cell 73 1993 457 467
17. J. Rothe, W. Lesslauer, and H. Lotscher Mice lacking the tumour necrosis factor receptor 1 are resistant to TNF-mediated toxicity but highly susceptible to infection by Listeria monocytogenes Nature 364 1993 798 802
18. R. Ross Atherosclerosis - an inflammatory disease N. Engl. J. Med. 340 1999 115 126
19. M. Cesari, Penninx BWJH, and A.B. Newman Inflammatory markers and onset of cardiovascular events: results from the health ABC study Circulation 108 2003 2317 2322
20. Zimmermann MA, Reznikov LL, Sorensen AC, Selzman CH. Relative contribution of the TNF-α receptors to murine intimal hyperplasia. Am J Physiol Regul Integr Comp Physiol 2003;284:R1213-8.
21. M.A. Zimmerman, C.H. Selzman, and L.L. Reznikov Lack of TNFα attenuates intimal hyperplasia following mouse carotid injury Am. J. Physiol. Regul. Integr. Comp. Physiol. 283 2002 R505 R512
22. S.A. Schreyer, J.J. Peschon, and R.C. LeBoeuf Accelerated atherosclerosis in mice lacking tumor necrosis factor receptor p55 J. Biol. Chem. 271 1996 26174 26178
23. S.A. Schreyer, C.M. Vick, and R.C. LeBoeuf Loss of lymphotoxin-α but not tumor necrosis factor-α reduces atherosclerosis in mice J. Biol. Chem. 277 2002 12364 12368
24. M.E. Rosenfeld, P. Polinsky, and R. Virmani Advanced atherosclerotic lesions in the innominate artery of the apoE knockout mouse Arterioscler. Thromb. Vasc. Biol. 20 2000 2587 2592
25. F. Bea, E. Blessing, and B. Bennett Simvastatin promotes plaque stability in ApoE-deficient mice independently of lipid lowering Arterioscler. Thromb. Vasc. Biol. 22 2002 1832 1837
26. F. Bea, E. Blessing, and M.I. Shelley Simvastatin inhibits expression of tissue factor in advanced atherosclerotic lesions in apolipoprotein E deficient mice independent of lipid lowering: potential role of simvastatin-mediated inhibition of Egr-1 expression and activation Atherosclerosis 167 2003 187 194
27. F. Bea, E. Blessing, and B.J. Bennett Chronic inhibition of cyclooxygenase-2 does not alter plaque composition in a mouse model of advanced unstable atherosclerosis Cardiovasc. Res. 60 2003 198 204
28. P. Libby Molecular bases of the acute coronary syndromes Circulation 91 1995 2844 2850
29. P. Libby Current concepts of the pathogenesis of the acute coronary syndromes Circulation 104 2002 365 372
30. L. Zheng, G. Fisher, and R.E. Miller Induction of apoptosis in mature T cells by tumour necrosis factor Nature 377 1995 348 351
31. M. Matsumoto, S. Mariathasan, and M.H. Nahm Role of lymphotoxin and the type I TNF receptor in the formation of germinal centers Science 271 1996 1289 1291
32. F. Mackay, P.R. Bourdon, and D.A. Griffiths Cytotoxic activities of recombinant soluble murine lymphotoxin-alpha and lymphotoxin-alpha beta complexes J. Immunol. 159 1997 3299 3310
33. H.Z. Movat Demonstration of all connective tissue components in a single section Arch. Pathol. 60 1955 289 295
34. Mallory FB. Pathological techniques. 2nd ed. Philadelphia, PA: W.B. Saunders Co.; 1942.